| Particulars |
|
|
|
| Company Name
| Glaxosmithkline Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
169.41 |
B.V. (₹) |
115.10 |
| Sales(₹ Cr.) |
3,723.49 |
NP (₹ Cr.) |
865.43 |
| NP Var% |
33.00 |
Div% |
540.00 |
| CPS(₹) |
55.00 |
EPS (₹) |
51.10 |
| Traded Value(₹ Lakhs) |
104.44 |
52 Week High |
3,516.00 |
| 52 Week Low |
1,924.00 |
Price BSE |
2,649.00 |
| Price NSE |
2,651.00 |
Market Capital (₹ Cr.) |
44,867.19 |
| P/C Ratio |
48.10 |
P/E Ratio |
51.90 |
| Price Vs.BV |
23.01 |
|
| Latest Quarter |
| Year End |
202506 |
Sales (₹ Cr.) |
804.83 |
| NP(₹ Cr.) |
204.70 |
NP Var % |
13.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
3,526.90 |
| OPM |
24.19 |
NP |
795.84 |
| NP Var% |
22.55 |
EPS |
55.42 |
| PE |
47.79 |
|
|